FDA DISCLAIMER ON HCG
ROLE OF THE FDA
hCG is a human byproduct that exists in a pregnant woman’s body and has been known and safely used by the world wide medical community to treat various health issues and for testing to determine if a women is pregnant. Even so, the FDA has not approved hCG therapy for the specific treatment of obesity. To this date, no research documentation, from a recognized testing agency, has been presented to the FDA proving or disproving that hCG has been or has not been successful in reducing obesity.
hCG has not been demonstrated to be effective adjunctive therapy in the treatment of obesity. There is no substantial evidence that it increases weight loss beyond that resulting from caloric restriction, that it causes a more attractive or “normal” distribution of fat or that it decreases the hunger and discomfort associated with calorie- restricted diets.